Cogent Biosciences, Inc. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
Cogent Biosciences, Inc. (COGT) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2021-03-16
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2020-03-31 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2019-12-31 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2019-09-30 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2019-06-30 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2019 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2018 was $0.00.
- Cogent Biosciences, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2017 was $0.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | $0.00 derived: sum of 3 quarters · filed 2020-05-11 | $0.00 derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 derived: sum of 3 quarters · filed 2020-05-11 | $0.00 derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $0.00 derived: sum of 3 quarters · filed 2020-03-26 | $0.00 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | $0.00 derived: sum of 3 quarters · filed 2019-08-12 | $0.00 derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | $0.00 derived: sum of 2 quarters · filed 2019-05-13 | $0.00 derived: sum of 3 quarters · filed 2019-05-13 | $0.00 derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $0.00 derived: sum of 2 quarters · filed 2019-03-28 | $0.00 derived: sum of 3 quarters · filed 2019-03-28 | $0.00 10-K · filed 2019-03-28 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |